The Pharmaceutical Authority launches a national drug constitution with international standards with more than 3000 infiltrators
The Egyptian Pharmaceutical Authority announced the issuance of the Egyptian pharmaceutical constitution, which includes more than 3000 medication and a public chapter, representing about 90% of the total target of 3400 monogerohs, which is scheduled to be completed by the end of 2025, and this comes within the framework of its continuous efforts to consolidate Egypt’s leadership in the pharmaceutical industries sector and localization of pharmaceutical knowledge according to scientific foundations Fun. Where the British Drug Constitution, which includes about 4000 monoographies, and the US drug constitution, approximately 5,000 monozrefs, as well as surpassing the constitution of European drugs, which includes about 2900 monozroor. An independent national pharmaceutical reference that adheres to the latest scientific and technical standards, where the launch of the Egyptian drug constitution represents an important historical station in the march of the national drug industry; Where it enhances the concept of pharmaceutical and cognitive sovereignty, and enables the regulatory authorities and local companies to rely on accurate and updated specifications, compatible with the nature of the Egyptian market and supports expansion plans in foreign markets. For this vital sector.
